HN2002000278A - Tetrahidroquinolinas - Google Patents
TetrahidroquinolinasInfo
- Publication number
- HN2002000278A HN2002000278A HN2002000278A HN2002000278A HN2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A HN 2002000278 A HN2002000278 A HN 2002000278A
- Authority
- HN
- Honduras
- Prior art keywords
- tetrahydroquinolins
- medicines
- procedures
- preparation
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A TETRAHIDROQUINOLINAS SUSTITUIDAS A PROCEDIMIENTOS PARA SU PREPARACIÓN Y SU USO EN MEDICAMENTOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10148436A DE10148436A1 (de) | 2001-10-01 | 2001-10-01 | Tetrahydrochinoline |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2002000278A true HN2002000278A (es) | 2002-12-20 |
Family
ID=7701007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2002000278A HN2002000278A (es) | 2001-10-01 | 2002-10-01 | Tetrahidroquinolinas |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050043341A1 (es) |
EP (1) | EP1434581A1 (es) |
JP (1) | JP2005508341A (es) |
AR (1) | AR036583A1 (es) |
CA (1) | CA2462030A1 (es) |
DE (1) | DE10148436A1 (es) |
DO (1) | DOP2002000457A (es) |
GT (1) | GT200200195A (es) |
HN (1) | HN2002000278A (es) |
PE (1) | PE20030604A1 (es) |
UY (1) | UY27458A1 (es) |
WO (1) | WO2003028727A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005030185A2 (en) * | 2003-09-26 | 2005-04-07 | Japan Tobacco Inc. | Method of inhibiting remnant lipoprotein production |
KR20060085675A (ko) | 2003-10-08 | 2006-07-27 | 일라이 릴리 앤드 캄파니 | 이상지혈증 치료를 위한 화합물 및 방법 |
PT1732933E (pt) | 2004-03-26 | 2008-10-20 | Lilly Co Eli | Compostos para o tratamento da dislipidémia |
BRPI0519566A2 (pt) * | 2004-12-18 | 2009-01-27 | Bayer Healthcare Ag | derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp |
AU2005315770B2 (en) * | 2004-12-18 | 2011-12-08 | Bayer Schering Pharma Aktiengesellschaft | 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
DE102006012548A1 (de) | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
CN101096363B (zh) | 2006-06-27 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途 |
US20080145498A1 (en) * | 2006-12-14 | 2008-06-19 | Kraft Foods Holdings, Inc. | Texture and shape control process for acidified food products |
PL2268644T3 (pl) * | 2008-03-05 | 2012-01-31 | Boehringer Ingelheim Int | Tricykliczne pochodne piperydyny, leki zawierające te związki, ich zastosowanie i sposoby ich wytwarzania |
US20120053197A1 (en) * | 2010-02-19 | 2012-03-01 | Boehringer Ingelheim International Gmbh | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
WO2012005343A1 (ja) | 2010-07-09 | 2012-01-12 | 第一三共株式会社 | 置換ピリジン化合物 |
US9150583B2 (en) | 2011-08-17 | 2015-10-06 | Boehringer Ingelheim International Gmbh | Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
CA2860601C (en) | 2012-01-06 | 2016-07-05 | Daiichi Sankyo Company, Limited | Acid addition salt of substituted pyridine compound |
US9938228B2 (en) | 2014-09-09 | 2018-04-10 | Boehringer Ingelheim International Gmbh | Process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dione |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP970330B1 (en) * | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
MA24643A1 (fr) * | 1997-09-18 | 1999-04-01 | Bayer Ag | Tetrahydro-naphtalenes substitues et composes analogues |
DE19741051A1 (de) * | 1997-09-18 | 1999-03-25 | Bayer Ag | Hetero-Tetrahydrochinoline |
DE19741399A1 (de) * | 1997-09-19 | 1999-03-25 | Bayer Ag | Tetrahydrochinoline |
-
2001
- 2001-10-01 DE DE10148436A patent/DE10148436A1/de not_active Withdrawn
-
2002
- 2002-09-02 DO DO2002000457A patent/DOP2002000457A/es unknown
- 2002-09-18 WO PCT/EP2002/010444 patent/WO2003028727A1/de active Application Filing
- 2002-09-18 CA CA002462030A patent/CA2462030A1/en not_active Abandoned
- 2002-09-18 US US10/491,465 patent/US20050043341A1/en not_active Abandoned
- 2002-09-18 JP JP2003532059A patent/JP2005508341A/ja active Pending
- 2002-09-18 EP EP02772317A patent/EP1434581A1/de not_active Withdrawn
- 2002-09-25 AR ARP020103608A patent/AR036583A1/es unknown
- 2002-09-27 GT GT200200195A patent/GT200200195A/es unknown
- 2002-09-27 UY UY27458A patent/UY27458A1/es not_active Application Discontinuation
- 2002-09-30 PE PE2002000962A patent/PE20030604A1/es not_active Application Discontinuation
- 2002-10-01 HN HN2002000278A patent/HN2002000278A/es unknown
Also Published As
Publication number | Publication date |
---|---|
UY27458A1 (es) | 2003-04-30 |
DE10148436A1 (de) | 2003-04-17 |
US20050043341A1 (en) | 2005-02-24 |
PE20030604A1 (es) | 2003-09-07 |
AR036583A1 (es) | 2004-09-15 |
GT200200195A (es) | 2003-08-22 |
WO2003028727A1 (de) | 2003-04-10 |
CA2462030A1 (en) | 2003-04-10 |
EP1434581A1 (de) | 2004-07-07 |
JP2005508341A (ja) | 2005-03-31 |
WO2003028727A9 (de) | 2003-11-13 |
DOP2002000457A (es) | 2003-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2001000281A (es) | Nuevas imidazotriazinonas sustituidas | |
ITTO20010008A0 (it) | Formulazione farmaceutica | |
NO20071303L (no) | Farmasoytiske preparater | |
NO20033556D0 (no) | Farmasöytiske preparater | |
ATE468324T1 (de) | Pharmazeutische zusammensetzung | |
NO20033384L (no) | Farmasoytisk formulering | |
HN2002000150A (es) | Agentes antibacteriano | |
EE200300416A (et) | Ravimvorm | |
DE60118008D1 (de) | Pharmazeutische zusammensetzungen mit amlodipinmaleat | |
HN2002000300A (es) | Nuevos derivados de piperazina | |
SG146442A1 (en) | Sulphonamide derivatives, their preparation and use as medicaments | |
HN2002000278A (es) | Tetrahidroquinolinas | |
NO20035627D0 (no) | Farmasöytisk formulering | |
BR0114903A (pt) | 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação | |
BR0114254B1 (pt) | distractor maxilar para modificação da distáncia entre o maxilar e o zigoma. | |
DE50108437D1 (de) | Flachflächen-Schnellkupplung | |
DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
ATE366128T1 (de) | Pharmazeutische zusammensetzung | |
UY26556A1 (es) | Compuestos calcilíticos | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
ES1050889Y (es) | Articulo para masticar | |
PT1385512E (pt) | Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos | |
DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
HN2002000052A (es) | Derivados de difenilo | |
HN2002000049A (es) | Nuevos compuestos antiinflamatorios de triazolopiridinas |